Quest Diagnostics Inc. Stock Underperforms Monday When Compared To Competitors
Quest Diagnostics Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
本文由MarketWatch使用Automated Insights的技術自動生成。
Shares of Quest Diagnostics Inc. (DGX) slid 1.01% to $145.01 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.47% to 4,566.48 and the Dow Jones Industrial Average rising 0.18% to 35,741.15. Quest Diagnostics Inc. closed $15.55 below its 52-week high ($160.56), which the company achieved on September 9th.
週一，Quest Diagnostics Inc.股價下跌1.01%，至145.01美元，這是一個對股市全面有利的交易日，標準普爾500指數上漲0.47%，至4566.48點，道瓊斯工業平均指數上漲0.18%，至35,741.15點。Quest Diagnostics Inc.的收盤價比該公司9月9日創下的52周高點(合160.56美元)低15.55美元。
The stock underperformed when compared to some of its competitors Monday, as Laboratory Corp. of America Holdings (LH) fell 0.38% to $281.07, Qiagen N.V. (QGEN) rose 0.48% to $54.25, and Sonic Healthcare Ltd. ADR rose 0.71% to $29.92. Trading volume (1.3 M) eclipsed its 50-day average volume of 1.3 M.
與一些競爭對手相比，該股週一表現不佳，美國實驗室控股公司(Laboratory Corp.of America Holdings)下跌0.38%，至281.07美元，啟根公司(Qiagen N.V.)上漲0.48%，至54.25美元，Sonic Healthcare Ltd.ADR上漲0.71%，至29.92美元。成交量(130萬)超過了其50天平均成交量130萬。
Data source: Dow Jones Market Data, FactSet. Data compiled October 25, 2021.
數據來源：道瓊斯市場數據，FactSet。數據彙編於2021年10月25日。
-MarketWatch Automation
-MarketWatch自動化